Abstract Search

ea0016oc4.9 | Bone and adrenal | ECE2008

Teriparatide (TPTD) treatment followed by either zoledronic acid (ZOL) 5 mg once yearly or strontium ranelate (SR) 2 g daily: preliminary results from the ZOSTER-Study

Riedmuller Gunter , Fahrleitner Astrid , Dobnig Harald , Piswanger Claudia , Stiegler Claudia , Stepan Vinzenz , Obermayer-Pietsch Barbara , Hans-Peter Dimai

Background: TPTD treatment has been shown to reduce vertebral and non-vertebral fracture risk in postmenopausal osteoporosis efficiently. However, gains in bone mass achieved by this treatment are almost lost 2 years after cessation of treatment, unless consecutively followed by an antiresorptive treatment such as alendronate.Subjects and methods: In the present prospective randomised open-labelled study in 52 pmp women, we investigated the effect of eit...

0 shares

ea0063p409 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Diagnostic accuracy of the aldosterone to active renin ratio in detecting primary aldosteronism: the graz endocrine causes of hypertension (GECOH) study

Pilz Stefan , Keppel Martin , Trummer Christian , Theiler-Schwetz Verena , Pandis Marlene , Borzan Valentin , Pittrof Matthias , Obermayer-Pietsch Barbara , Grubler Martin R , Verheyen Nicolas , Stepan Vinzenz , Meinitzer Andreas , Voelkl Jakob , Marz Winfried , Tomaschitz Andreas

Context: The aldosterone to active renin ratio (AARR) is the recommended screening test for primary aldosteronism (PA), but prospective study data on its sensitivity and specificity are sparse.Objective: We investigated the diagnostic accuracy of the AARR for detecting PA.Design: This is a prospective diagnostic accuracy study.Setting: This study was conducted from February 2009 to August 2015 at the outpatie...

0 shares

Endocrine Abstracts

Teriparatide (TPTD) treatment followed by either zoledronic acid (ZOL) 5 mg once yearly or strontium ranelate (SR) 2 g daily: preliminary results from the ZOSTER-Study

Diagnostic accuracy of the aldosterone to active renin ratio in detecting primary aldosteronism: the graz endocrine causes of hypertension (GECOH) study

BiosciAbstracts